Veterinary Medicines

TRIMETOX, geriamieji milteliai

Authorised
  • Trimethoprim
  • Sulfamerazine
Download as PDF

Product identification

Medicine name:
TRIMETOX, geriamieji milteliai
Active substance:
  • Trimethoprim
  • Sulfamerazine
Target species:
  • Horse
  • Cattle
  • Pig
  • Sheep
  • Mink
  • Cattle (calf)
  • Horse (foal)
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Trimethoprim
    32.00
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfamerazine
    160.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In-feed use
    • Horse
      • Meat
        10
        day
    • Cattle
      • Meat
        10
        day
      • Milk
        2
        day
    • Pig
      • Meat
        12
        day
    • Sheep
      • Meat
        12
        day
      • Milk
        2
        day
    • Mink
    • Cattle (calf)
    • Horse (foal)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1370/001-002
Date of authorisation status change:

Documents

RV1370.pdf

Lithuanian (PDF)
Published on: 30/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."